T2 Biosystems, Inc.
TTOODelisted Jul 10, 2025- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001492674
T2 Biosystems, Inc. was delisted on Jul 10, 2025; its insiders filed their last Form 4 on Jan 2, 2025; 1 institution reported holding it in 13F filings for Q2 2025, worth $0 in total; no superinvestor held it.
Q4 2023 vs. Q3 2023
How the institutions holding T2 Biosystems, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 44 | 21 | −23 |
| SharesConverted for a 1-for-100 split | 186.2K | 218.1K | +31.9K (+17.1%) |
| Value | $4.06M | $1.37M | −$2.69M (−66.3%) |
New holders (4)
Institutions that held T2 Biosystems, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Virtu Financial LLC | 10,078 | $63.0K | 0.00% |
| Royal Bank of Canada | 1,302 | $8.00K | 0.00% |
| Signature Resources Capital Management, LLC | 90 | $565 | 0.00% |
| Game Plan Financial Advisors, LLC | 33 | $207 | 0.00% |
Sold out (27)
Institutions that held T2 Biosystems, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.